Osteocyte viability with glucocorticoid treatment: relation to histomorphometry - Wikidata - wikimedia - TriplyDB

Osteocyte viability with glucocorticoid treatment: relation to histomorphometry

Osteocyte viability with glucocorticoid treatment: relation to histomorphometry

http://www.wikidata.org/entity/Q35552295

about

Glucocorticosteroid-induced osteoporosis in adult primiparous Göttingen miniature pigs: effects on bone mineral and mineral metabolism.Glucocorticoids, osteocytes, and skeletal fragility: the role of bone vascularity.Glucocorticoid-induced osteoporosis: treatment update and review.Expression of HCA2 Receptors in Femoral Epiphysis and Metaphysis of Rats with Dexamethasone-Induced Osteoporosis Osteoblasts play key roles in the mechanisms of action of strontium ranelate.The role of Wnt signaling and sclerostin in the pathogenesis of glucocorticoid-induced osteoporosis.Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and O

P2860

Q33282690-B41C5C15-346A-44E6-8BC5-35BB5937A6D4 Q33665237-AD2C6770-9AAC-426E-86E6-CB6C41484BBE Q36059394-C929E704-F8C0-4652-AC47-707342680998 Q37099608-1DD12291-196F-467E-9658-F0E98C11222A Q37346557-67E54027-9E1E-4BD9-9BAF-1E86C070FECF Q38184470-B808A088-C3BA-4E89-A800-2AAD33E5122F Q58621582-8D926F57-8426-44F0-B709-0912A60A5AC4

P2860

Osteocyte viability with glucocorticoid treatment: relation to histomorphometry

http://www.wikidata.org/entity/Q35552295

description

2003 nî lūn-bûn

@nan

2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Osteocyte viability with glucocorticoid treatment: relation to histomorphometry

@ast

Osteocyte viability with glucocorticoid treatment: relation to histomorphometry

@en

type

label

Osteocyte viability with glucocorticoid treatment: relation to histomorphometry

@ast

Osteocyte viability with glucocorticoid treatment: relation to histomorphometry

@en

prefLabel

Osteocyte viability with glucocorticoid treatment: relation to histomorphometry

@ast

Osteocyte viability with glucocorticoid treatment: relation to histomorphometry

@en

P1433

Q35552295-1CAFD93D-37D5-4E3E-9E94-D1EA57D1448D

P1476

Q35552295-0884D357-FDBC-4406-AE15-C22CF8628C03

P2093

Q35552295-5D5CC2D8-F152-47A2-8380-0DBC352ACE42

Q35552295-7751FFC0-EEFA-4213-BDB3-D14EE9EFE52E

Q35552295-C637532B-09BA-40B7-82D5-9A24A17F39EA

Q35552295-D79257F9-CBA0-4912-BE88-BD11BAB64828

Q35552295-FA3DA001-0391-41FF-B20A-C610B13D7B8E

P2860

Q35552295-4F4855C5-E4AC-498E-873C-B7D6E25275CA

Q35552295-763BAF46-5650-4CB6-9DCB-477A64F9126A

Q35552295-9E3608A5-E214-4577-AAC4-5239F3911957

Q35552295-ABA7633E-D868-496C-B86F-68FAF66200BD

Q35552295-B69C7C1E-42E3-430D-920F-EAD68DDA8D6F

Q35552295-BCB6210D-4920-4435-BE72-98D318FE97DD

Q35552295-C601FB34-8FAD-45DB-B093-C395604E760E

Q35552295-C785765E-E661-4A4B-97E0-A65F98C2D7D9

Q35552295-D88B169E-0169-4133-91BB-0C3350944AC0

Q35552295-E84BEFC0-8011-4053-8B3F-C93F17AF5A41

P304

Q35552295-EE0DCA87-FB12-48B1-BEC3-295E86D3EE32

P31

Q35552295-1599769F-42B1-453E-87E6-D6FF1A803C34

P356

Q35552295-39118830-FC70-41EF-8B2B-814D95E968DE

P407

Q35552295-7795739A-5193-4D4B-81DF-12ABFBF16DB3

P433

Q35552295-E788EC2B-7C2B-491E-BF4F-B795515F93EF

P478

Q35552295-F37BBE55-F0E8-43AE-87B9-037CDAEAAD9C

P577

Q35552295-0102C529-C6CE-444A-A2FE-03C66B2294F8

P5875

Q35552295-3D7E08A8-2F1A-4B37-86FB-133ACD9D2973

P698

Q35552295-68F2E9CF-3239-4EFC-B7C7-DB89BEB766F5

P932

Q35552295-360A91E8-6826-493A-9752-6E051A75C5F3

P356

ARD.2003.008839

P1433

Annals of the Rheumatic Diseases

P1476

Osteocyte viability with glucocorticoid treatment: relation to histomorphometry

@en

P2093

Hughes DR

http://www.w3.org/2001/XMLSchema#string

Mason RS

http://www.w3.org/2001/XMLSchema#string

Nelson AE

http://www.w3.org/2001/XMLSchema#string

Robinson BG

http://www.w3.org/2001/XMLSchema#string

Sambrook PN

http://www.w3.org/2001/XMLSchema#string

P2860

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females.

Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids.

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone

Bone histomorphometry in glucocorticoid-induced osteoporosis.

Osteocyte death and hip fracture.

Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis.

The determination of bone viability: a histochemical method for identification of lactate dehydrogenase activity in osteocytes in fresh calcified and decalcified sections of human bone.

Age and distance from the surface but not menopause reduce osteocyte density in human cancellous bone.

Altered trabecular architecture induced by corticosteroids: a bone histomorphometric study.

P304

1215-1217

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ARD.2003.008839

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P577

2003-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8985442

http://www.w3.org/2001/XMLSchema#string

P698

14644862

http://www.w3.org/2001/XMLSchema#string

P932

1754416

http://www.w3.org/2001/XMLSchema#string